Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: a prospective observational trial.
Daryl S HenshawChristopher J EdwardsSean W DobsonDoug JaffeJames D TurnerJ Wells ReynoldsGarrett R ThompsonGreg RussellRobert WellerPublished in: Regional anesthesia and pain medicine (2023)
NCT03296033.